There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chemomab Therapeutics (CMMB – Research Report) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Blueprint Medicines (BPMC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Blueprint Medicines has a 12-month low of $72.24 and a 12-month high of $121.90. The company has a market cap of $7.01 billion, a price-to-earnings ratio of -52.31 and a beta of 0.61. Insider Activity ...

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma ...

Union Budget Latest Updates | Union Finance Minister Nirmala Sitharaman tabled new Union Budget for the Country on February 1. Finance Minister Nirmala Sitharaman, during her Union Budget 2025 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...